AbbVie
ABBV
#27
Rank
A$594.21 B
Marketcap
$336.60
Share price
1.96%
Change (1 day)
22.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $5.55

According to AbbVie's latest financial reports the company's current EPS (TTM) is $5.93. In 2022 the company made an earnings per share (EPS) of $10.72 an increase over its 2021 EPS that were of $10.45.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.55-48.28%
2022$10.722.63%
2021$10.45125.21%
2020$4.64-45.69%
2019$8.5448.35%
2018$5.767.6%
2017$5.35-9.3%
2016$5.9015.48%
2015$5.11185.53%
2014$1.79-57.11%
2013$4.17-21.69%
2012$5.3355.73%
2011$3.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.00-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.39 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.74 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.79 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.07 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.73 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.64-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.20-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.16-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA